#glp-1-consumer-market

[ follow ]
#weight-loss #glp-1-drugs #glp-1-medications #glp-1 #obesity-treatment #fda-approval #obesity #semaglutide
#glp-1-medications
Public health
fromInsideHook
2 months ago

Research Suggests GLP-1 Drugs Could Be for the Long Haul

People using GLP-1 weight-loss medications often require long-term or lifelong treatment because stopping them commonly leads to rapid weight regain and lost metabolic benefits.
Wellness
fromPsychology Today
1 month ago

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.
Alternative medicine
fromFast Company
2 days ago

With GLP1 drug ads everywhere, here's what to know to safely buy them online

GLP-1 medications for weight loss are increasingly advertised, raising concerns about safety and the rise of unregulated alternatives.
Medicine
fromPsychology Today
1 week ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.
Wellness
fromPsychology Today
1 month ago

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.
more#glp-1-medications
#glp-1-drugs
fromIndependent
3 days ago
Medicine

'If you are eating six smaller meals, you've doubled your sugar attacks. So you've got increased risk of tooth decay' - Measuring the effects of GLP-1s on Irish society

fromIndependent
3 days ago
Medicine

Long read: 'Weight-loss jabs have been hijacked by Hollywood and middle-upper-income people' - Measuring the effects of GLP-1s on Irish society

fromIndependent
3 days ago
Medicine

'Weight-loss jabs have been hijacked by Hollywood and middle-upper-income people' - Measuring the effects of GLP-1s on Irish society

Food & drink
fromTasting Table
1 month ago

How GLP-1 Is Reshaping Restaurant Menus In 2026 - Tasting Table

GLP-1 drugs for weight loss are reshaping restaurant menus in 2026, driving major chains to introduce smaller portions and lighter meal options.
Health
fromHarvard Gazette
2 months ago

Pricey blockbuster GLP-1s are costing users - and most of the rest of us, too - Harvard Gazette

Widespread GLP-1 use and high prices are significantly increasing health insurance premiums and prompting insurers and states to restrict or alter coverage.
Medicine
fromIndependent
3 days ago

'If you are eating six smaller meals, you've doubled your sugar attacks. So you've got increased risk of tooth decay' - Measuring the effects of GLP-1s on Irish society

GLP-1 drugs improve obesity treatment but may contribute to body acceptance issues and societal stigma.
Silicon Valley food
fromInsideHook
1 week ago

How Are GLP-1 Drugs Reshaping the Hot Sauce Market?

GLP-1 drugs are influencing food trends, leading to increased sales for hot sauce manufacturers like Tapatío due to consumer demand for bold flavors.
Medicine
fromIndependent
3 days ago

Long read: 'Weight-loss jabs have been hijacked by Hollywood and middle-upper-income people' - Measuring the effects of GLP-1s on Irish society

GLP-1 drugs improve obesity treatment but may contribute to body acceptance issues and societal stigma.
Medicine
fromIndependent
3 days ago

'Weight-loss jabs have been hijacked by Hollywood and middle-upper-income people' - Measuring the effects of GLP-1s on Irish society

GLP-1 drugs improve obesity treatment but may contribute to body image issues and societal stigma.
more#glp-1-drugs
#glp-1
Medicine
fromThe Atlantic
1 week ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
Medicine
fromFast Company
2 weeks ago

A new weight loss pill is here and it could reshape the GLP-1 market

Eli Lilly's GLP-1 pill, Foundayo, approved for obesity treatment, shows significant weight loss results and aims for affordability.
SF food
fromwww.npr.org
3 weeks ago

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.
Medicine
fromThe Atlantic
1 week ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
more#glp-1
Cancer
fromwww.theguardian.com
6 days ago

GSK reports promising early results in ovarian and womb cancer drug trial

GSK's Mo-Rez treatment shows promising results in shrinking tumors for ovarian and endometrial cancers, leading to plans for late-stage trials.
Medicine
fromwww.bbc.com
1 day ago

'I'm in remission for the first time due to new cancer drug'

A woman with multiple sclerosis reached remission from myeloma after surpassing her prognosis of three to seven years, thanks to a new drug.
Healthcare
fromTechCrunch
3 weeks ago

Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing | TechCrunch

VITL provides an e-prescribing platform tailored for cash-pay medical businesses, significantly improving prescription management efficiency for clinics.
#weight-loss
Medicine
fromScienceDaily
5 days ago

Stanford scientists discover "natural Ozempic" without side effects

A newly discovered molecule, BRP, reduces appetite and promotes fat loss without the side effects of Ozempic.
Medicine
fromwww.bbc.com
1 week ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
Medicine
fromABC7 New York
2 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
Medicine
fromwww.theguardian.com
2 weeks ago

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.
Medicine
fromScienceDaily
5 days ago

Stanford scientists discover "natural Ozempic" without side effects

A newly discovered molecule, BRP, reduces appetite and promotes fat loss without the side effects of Ozempic.
Medicine
fromwww.bbc.com
1 week ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
Medicine
fromABC7 New York
2 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
Medicine
fromwww.theguardian.com
2 weeks ago

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.
more#weight-loss
#novo-nordisk
more#novo-nordisk
from24/7 Wall St.
1 week ago

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Lilly's fourth quarter revenue reached $19.29 billion, up 42.6% year-over-year, powered almost entirely by two products. Mounjaro generated $7.41 billion, up 110%, while Zepbound added $4.26 billion, up 123%.
Medicine
#fda-approval
Medicine
fromwww.scientificamerican.com
2 weeks ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
more#fda-approval
#obesity
Medicine
fromWIRED
2 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromWIRED
2 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
more#obesity
#glp-1-agonists
more#glp-1-agonists
Marketing
fromDigiday
2 months ago

GLP-1 draws pharma advertisers to double down on the Super Bowl

Pharmaceutical and healthcare brands are heavily advertising GLP-1 and related products during the Super Bowl despite potential regulatory threats to pharma advertising.
Public health
fromBBC
2 months ago

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Weight loss drugs were used by over 1.5 million UK adults in 2024–25 and can cause side effects including nausea and painful gallstones.
Health
fromIrish Independent
2 months ago

Real Health: From Stigma to Science: Aimee Donnellan on Ozempic

Weight-loss drugs like Ozempic rapidly shifted from a niche medical treatment to a global phenomenon reshaping business, society, and the food industry.
Healthcare
fromThe Atlantic
2 months ago

GLP-1 Envy Was Just the Beginning

Telehealth companies market paid services that promise wealthy-style, personalized concierge care, highlighting and monetizing the divide between elite proactive care and reactive mainstream care.
Healthcare
from24/7 Wall St.
1 month ago

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Novo Nordisk's stock dropped 22% weekly and 56% yearly after CagriSema trial failure and announced price cuts on flagship drugs, causing analyst downgrades and declining Reddit sentiment.
Medicine
fromwww.scientificamerican.com
1 month ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
#glp-1-receptor-agonists
Medicine
fromwww.theguardian.com
1 month ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Medicine
fromwww.theguardian.com
1 month ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
more#glp-1-receptor-agonists
fromwww.theguardian.com
1 month ago

Weight-loss jab could be made for $3 a month, study finds

New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about 2.35) for a monthly dose in its injectable form. Newer formulations, taken as a pill rather than an injection, could be made for about $16 a month.
Medicine
[ Load more ]